Supplementary Figure 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
James P. Sullivan(Australian National University), Daniel A. Haber(Howard Hughes Medical Institute), Samantha M. Oliveira(Massachusetts General Hospital), Marissa W. Madden(Harvard University), S. Michael Rothenberg(Pfizer (United States)), David N. Louis(Massachusetts General Hospital), Ravi Kapur(Harvard University), Khalid Shah(Harvard University), Deepak Bhere(Harvard University), Simeon Springer(Howard Hughes Medical Institute), A. John Iafrate(Peter MacCallum Cancer Centre), William T. Curry(Harvard University), Tracy T. Batchelor(Massachusetts General Hospital), Shyamala Maheswaran(Massachusetts General Hospital), Lecia V. Sequist(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Brian V. Nahed(Harvard University), Jay S. Loeffler(Brigham and Women's Hospital), Hiroaki Wakimoto(Harvard University)
Cited by 0
Related Papers
The 2007 WHO Classification of Tumours of the Central Nervous System
|Acta Neuropathologica|2007|4.6k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k